16 results
Biologic Events Leading to Chronic GVHD #Pathophys #Honc #Pharm #GVHD #GraftVersusHostDisease #Therapeutic #Pathways #NEJM
GVHD #Pathophys #Honc ... #Pharm #GVHD #GraftVersusHostDisease ... Therapeutic #Pathways #NEJM
Signaling Mechanism of PD-1 and PD-L1 and Inhibition of PD-1 Signaling in Microsatellite-Instability–High Cancers. MHC1 denotes
Pathophysiology #Honc ... #Pharm #PD1 #PDL1 ... MicrosatelliteInstability #NEJM
Plasmacytomas and Plasma-Cell Leukemia - Physical examination revealed multiple exophytic subcutaneous lesions involving the arms and
stain) #Clinical #HONC ... #Derm #Plasmacytomas ... Leukemia #Smear #NEJM
Ecthyma Gangrenosum - A physical examination revealed a 2-cm hemorrhagic patch with an erythematous border (Panel
#Clinical #Derm ... #Honc #Ecthyma # ... #Neutropenic #NEJM
Pembrolizumab Response Rate by Tumor Type #EBM #Honc #Pharm #Pembrolizumab #Response #TumorType #Colorectal #Endometrial #Biliary #NEJM
Tumor Type #EBM #Honc ... #Pharm #Pembrolizumab ... Endometrial #Biliary #NEJM
Squamous-Cell Carcinoma of the Penis with Human Papillomavirus #Clinical #Derm #Honc #Penile #SCC #Glans #HPV #NEJM
Papillomavirus #Clinical #Derm ... #Honc #Penile # ... SCC #Glans #HPV #NEJM
Immune Checkpoint–Blocking Antibodies Approved by the Food and Drug Administration #Pharm #Honc #Checkpoint #Blockade #FDA #Antibodies
Administration #Pharm ... #Honc #Checkpoint ... #Indications #NEJM
Effect of Tolvaptan on the Estimated Glomerular Filtration Rate (GFR). #EBM #Nephro #Pharm #Tolvaptam #PCKD #PolyCysticKidneyDisease
Filtration Rate (GFR ... #EBM #Nephro #Pharm ... PolyCysticKidneyDisease #NEJM
Upper endoscopy revealed a pigmented mass in the duodenal bulb (Panel A) and two additional masses
#Clinical #GI #Derm ... #Honc #Melanoma ... EGD #Metastatic #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
Pathophysiology #IM #Honc ... #Pharm #GVHD #GraftVersusHostDisease ... Immunosuppression #NEJM